The insulin-like growth factor-1 (IGF-1) and its downstream effector Akt have been documented as survival factors in response to a variety of stress signals. In this study, we show that IGF-1 activates p21 protein expression in a p53-dependent manner. Inhibition of PI-3 kinase or ectopic expression of a dominant-negative Akt blocks the effect of IGF-1 on the upregulation of p21 expression. In addition, IGF-1 prevents the UV irradiation-mediated suppression of p21 and MDM2 expression. Furthermore, p21 is important for IGF-1-mediated cell survival upon UV irradiation. Taken together, these data indicate that IGF-1 may activate p21 in executing its survival function upon genotoxic insults.
Introduction
The insulin-like growth factor 1 (IGF-1) plays a critical role in cell survival, proliferation, and terminal differentiation for a variety of different cell types (reviewed in Stewart and Rotwein, 1996; Grimberg and Cohen, 2000; Carter et al., 2002; Sandhu et al., 2002) . IGF-1 has been shown to protect cells from apoptosis induced by a variety of stimuli such as overexpression of c-myc (Harrington et al., 1994) , treatment by chemotherapeutic agents (Geier et al., 1995; Gooch et al., 1999) , hypoxia (Matsui et al., 1999) , and UV (Kulik et al., 1997) . IGF-1 binds to its receptor, IGF-1R, resulting in autophosphorylation of IGF-1R, which in turn activates phosphatidylinositol 3-kinase (PI3 kinase) and its downstream target Akt (Datta et al., 1999) . In addition, IGF-1 is documented to activate MAP kinase and p38 stress kinase pathways (Stewart and Rotwein, 1996; Grimberg and Cohen, 2000) . Activation of Akt has been shown to be important in cell survival. Akt can directly phosphorylate and modulate a set of protein substrates that are critical for apoptosis, including BAD del Peso et al., 1997) , caspase 9 (Cardone et al., 1998) , forkhead family proteins (Biggs et al., 1999; Brunet et al., 1999; Kops et al., 1999) , and NF-kB activating kinase, IKK (Ozes et al., 1999; Romashkova and Makarov, 1999) . Overexpression of wild-type or a constitutively active form of Akt can protect cells from apoptotic signals, whereas expression of a catalytically inactive, dominant-negative Akt attenuates cell survival even in the presence of survival factors Kauffmann-Zeh et al., 1997; Kennedy et al., 1997; Kulik et al., 1997) . Recently, Akt has been show to target on p21 to regulate p21-mediated growth inhibition (Rossig et al., 2001; Zhou et al., 2001a) and on MDM2 to promote its nuclear localization and thereby repressing p53 activation (Mayo and Donner, 2001; Zhou et al., 2001b; Ashcroft et al., 2002; Gottlieb et al., 2002) .
The tumor suppressor protein p53 plays a central role in response to genotoxic stress resulting in cell cycle arrest or apoptosis (Lakin and Jackson, 1999; Vogelstein et al., 2000; Woods and Vousden, 2001) . DNA damage by ionizing radiation (IR), UV and chemotherapeutic agents activates a cascade of protein kinases, including ATM, ATR, Chk1, and Chk2, which leads to p53 phosphorylation at specific amino-acid residues and p53 activation (Meek, 1999; Vogelstein et al., 2000; Vousden, 2002; Vousden and Lu, 2002) . Activation of p53, in turn, stimulates expression of a set of downstream target genes involved in cell cycle regulation such as p21 and 14-3-3s (Polyak et al., 1996; Hermeking et al., 1997) and apoptosis-associated genes such as BAD (Miyashita and Reed, 1995) , IGF-BP3 (Buckbinder et al., 1995) , PIG3 , NOXA (Oda et al., 2000a) , p53AIP (Oda et al., 2000b) , and PUMA (Nakano and Vousden, 2001) .
The expression of specific downstream targets initiated by p53 is critical in the determination of cell fate. Accumulating evidence suggests that induction of p21 not only directs cell cycle arrest, but is also important for cell survival. Mouse embryo fibroblast cells lacking p21 are hypersensitive to induction of apoptosis . Similarly, targeted deletion of p21 in human colon cancer cell lines results in enhanced susceptibility to apoptosis induced by chemotherapeutic agents (Bunz et al., 1999) . On the other hand, ectopic expression of p21 can prevent cells from apoptosis (Gorospe et al., 1997; Asada et al., 1999; Xu and ElDeiry, 2000; Lawlor and Rotwein, 2000b) .
In this study, we examined the effect of IGF-1 on the p53 pathway in response to UV irradiation. We found that IGF-1 activates p21 protein expression in a p53-dependent manner. The IGF-1-mediated effect on p53 and p21 requires PI3 kinase and Akt. In addition, IGF-1 prevents the UV-mediated suppression of p21 and MDM2 expression. Furthermore, p21 is critical for the IGF-1 survival function upon UV damage. These data indicate that p21 plays an important role for IGF-1-mediated protection from UV-induced apoptosis.
Results

IGF-1 induces p21 expression
It has been established that p21 plays an important role in cell survival, we therefore examined whether the biological function of IGF-1 as a survival factor is linked to p21 function. Serum-starved MCF-7 cells were treated with an increasing dose of IGF-1 for 24 h. As shown in Figure 1a , IGF-1 treatment at 10-100 ng/ml led to upregulation of p21 protein levels as well as the MDM2 protein levels. As both p21 and MDM2 are downstream targets of p53, we then examined the expression of p53. Interestingly, p53 protein levels were also elevated upon IGF-1 treatment ( Figure 1a) .
We next examined the effects of IGF-1 on p21 expression during the time course of treatment. As shown in Figure 1b , the expression of p21 protein was induced upon IGF-1 treatment as early as 1-3 h. Expression of MDM2 protein was evidently upregulated at 6 h. However, the p53 protein levels were significantly increased at 24 h, but there was little difference at 1, 3, or 6 h. To understand the mechanism(s) by which IGF-1 affects p21 expression, we performed Northern blot analysis. The p21 mRNA levels were elevated up to fourfold after 24 h treatment with IGF-1 (Figure 1c) , suggesting that IGF-1 may activate p21 transcription. We then examined the effect of IGF-1 on the p21-luciferase reporter activity. As shown in Figure 1d , IGF-1 led to a twofold increase (Po0.05) in p21 reporter activity in serum-deprived MCF-7 cells. In addition, IGF-1 also led to a twofold increase in Figure 1 IGF-1 induces p21 and MDM2 expression. (a) MCF-7 cells grown to 60-70% confluence were incubated in serum-free DMEM media for 48 h prior to addition of the indicated amount of IGF-1. After 24 h treatment, lysates were prepared and equal amount of total protein was subjected to Western blot analysis using antibodies specific for MDM2, p53, p21, or actin. (b) MCF-7 cells were serum starved for 48 h prior to the treatment with IGF-1 at a final concentration of 50 ng/ml. Cells were harvested at the indicated time points. Equal amount of total protein was subjected to Western blot analysis. (c) Total RNA (15 mg) was separated and subjected to Northern blot analysis using a probe for human p21. 28S and 18S RNA were shown by ethidium bromide staining and were used to normalize the expression of p21 mRNA. Data shown are representative of two independent experiments. (d) Subconfluent MCF-7 cells in six-well tissue culture plates were transfected with a DNA mixture containing pCMV-b-gal and p21-luciferase reporter or MDM2-luciferase reporter. At 16 h after transfection, cells were serum-starved for 48 h prior to the addition of IGF-1 (50 ng/ml). Cell lysates were collected after 24 h treatment. The luciferase activity was normalized to b-gal activity and presented as the mean of two independent experiments performed in triplicate IGF-1 activates p21 to inhibit UV-induced cell death S.A. Murray et al MDM2 reporter activity. Taken together, these data suggest that IGF-1 can activate transcription of p21 and MDM2.
p53 plays a role in upregulation of p21 by IGF-1
Since both p21-and MDM2-luciferase reporters contain p53-responsive elements, the IGF-1-mediated upregulation of the reporter activities may be through the action of p53. Thus, we investigated the effects of IGF-1 on the expression of p21 and MDM2 in MCF-7 cells containing wild-type p53 and p53 null Saos-2 cells. As shown in Figure 2a , IGF-1 activated AKT in both MCF-7 and Saos-2 cells. However, whereas IGF-1 treatment led to a clear increase in the expression of p21 and MDM2 as well as an elevated p53 protein levels in MCF-7 cells, IGF-1 did not significantly elevate the expression of p21 or MDM2 in Saos-2 cells, which lack the expression of p53. We then further examined the effect of IGF-1 on wild-type or p53 À/À mouse embryo fibroblasts (MEFs) cells. Again, IGF-1 induced the expression of p21 in wild-type MEF cells, but not in p53 À/À MEF cells ( Figure 2b) . Notably, the basal levels of p21 protein were significantly lower in p53 À/À MEF cells when compared to the wild-type MEF cells. Therefore, these Figure 2 p53 plays a role in upregulation of p21 by IGF-1. (a) Subconfluent MCF-7 and Saos-2 cells were serum starved for 48 h in serum-free DMEM. Cells were then treated in serum-free DMEM containing 50 ng/ml IGF-1 for an additional 24 h, lysed, and subjected to Western blot analysis using antibodies specific to p53, MDM2, p21, pAKT, or actin. (b) Subconfluent wild-type (WT) and p53 null (p53 À/À ) MEF cells were serum starved for 48 h in DMEM containing 0.5% FBS and treated with 50 ng/ml IGF-1 with DMEM containing 0.5% FBS for an additional 24 h. Cells lysates were subjected to Western blot analysis. The low levels of p21 in p53 À/À MEF cells were shown from a longer exposure of the Western blot analysis. (c) Subconfluent MCF-7 cells were serum starved for 48 h in serum-free DMEM prior to the addition of IGF-1 at a final concentration of 50 ng/ml. At the times indicated, cells were collected and total RNA was isolated using Trizol Reagent. A measure of 10 mg of total RNA was separated and subjected to Northern Blot analysis using a probe specific to human p53 or actin. (d) MCF-7 cells were serum starved for 48 h prior to IGF-1 treatment (50 ng/ml). Cells were then treated with 50 mg/ml cycloheximide for an indicated time in the presence of IGF-1. A measure of 25 mg of total protein was separated by 10% SDS-PAGE and subjected to Western blot analysis for p53 or actin. The p53 protein levels were evaluated by scanning and normalized to actin. The percentage of remaining p53 protein was plotted versus time IGF-1 activates p21 to inhibit UV-induced cell death S.A. Murray et al data suggest that p53 plays a role in IGF-1 mediated upregulation of p21.
As p53 protein levels were elevated upon IGF-1 treatment, we examined whether IGF-1 affects p53 mRNA expression or p53 protein stability. Interestingly, IGF-1 did not significantly alter the steady-state levels of p53 mRNA (Figure 2c ) yet the p53 protein was stabilized upon IGF-1 treatment (Figure 2d ).
IGF-1 activates p21 through the PI-3 kinase-AKT signaling pathway
We next investigated the signaling pathway involved in IGF-1-mediated p21 activation. As shown in Figure 3a , IGF-1-mediated upregulation of p21 was effectively blocked by PI-3 kinase inhibitor (LY294002) but not by MAPK inhibitor (PD98059), or p38 stress kinase inhibitor (SB202190). Similarly, treatment with the PI-3 kinase inhibitor also blocked IGF-1-mediated activation of MDM2 and p53. These data suggest that the PI-3 kinase signaling pathway is required for activation of the p21 and the p53 pathway.
Since Akt is a critical downstream mediator of the IGF-1/PI-3 kinase signaling pathway and plays a central role in IGF-1-mediated survival function, we investigated whether Akt is involved in the IGF-1-mediated effect on p21. As shown in Figure 3b , IGF-1 treatment led to a significant p21 protein expression in UVirradiated MCF-7 cells. Infection of an adenovirus expressing HA-Akt, but not the control virus, led to a similar p21 protein expression with or without the presence of IGF-1. In addition, infection of a recombinant adenovirus expressing a dominant-negative Akt mutant (AktDN) effectively blocked IGF-1-mediated upregulation of p21. Thus, these results suggest that the Akt activity is both necessary and sufficient for IGF-1-mediated activation of p21.
IGF-1 prevents UV-mediated downregulation of p21 and MDM2
It has been shown that high-dose UV irradiation can effectively suppress expression of both p21 and MDM2 despite p53 protein accumulation (Lu et al., 1996; Wu and Levine, 1997; Oda et al., 2000b; Zeng et al., 2000) . We therefore examined the effect of IGF-1 on p21 protein expression upon UV irradiation. As shown in Figure 4 , UV irradiation at 40 J/m 2 effectively blocked the expression of p21 and MDM2 despite significant p53 protein accumulation (Figure 4b , compare lanes 1 and 3). However, expression of p21 and MDM2 was sustained in UV-irradiated cells treated in the presence of 50 ng/ml IGF-1 (Figure 4a , lane 6). Furthermore, UV irradiation (20 J/m 2 ) led to a significant suppression of p21 expression, which was totally rescued in the presence of IGF-1 (Figure 4c , lanes 5 and 6). As expected, AKT was activated by IGF-1 (Figure 4c ). Since IGF-1 has been shown to protect cells from UVinduced apoptosis (Kulik et al., 1997) , the effect of IGF-1 on p21 protein expression may be important in IGF-1 survival function upon UV irradiation.
IGF-1 protects MCF-7 cells from UV-induced apoptosis
Next, we examined the effect of IGF-1 on MCF-7 cell survival upon UV irradiation. Cell viability was reduced to 50% upon UV irradiation with a dose of 30 J/m 2 as measured by trypan blue exclusion assay, which was effectively rescued by the IGF-1 treatment. UV irradiation with 40 J/m 2 led to less than 20% of cell survival, which was increased to 50% in the presence of IGF-1 (Figure 5a ). The protective effect of IGF-1 on cell survival upon UV irradiation was also observed by an Figure 3 IGF-1 activates p21 through the PI-3 kinase-AKT signaling pathway. (a) Serum-deprived MCF-7 cells were treated for 45 min with either PI-3 kinase inhibitor LY294002 (10 mm), MAPK inhibitor PD98059 (50 mm), or p38 stress kinase inhibitor SB202190 (10 mm). Cells were then treated with IGF-1 (50 ng/ml) in the serum-free DMEM for 24 h. Cells were lysed and equal amount of total protein was subjected to Western blot analysis for MDM2, p53, p21, or actin. (b) Subconfluent MCF-7 cells were infected with a recombinant adenovirus encoding either an HA-tagged wild-type AKT (HA-Akt) or a catalytically inactive, dominant-negative mutant Akt (HA-AktDN) (Kitamura et al., 1998) . A recombinant adenovirus encoding the green florescent protein (control) was used in parallel. At 16 h postinfection, cells were serum starved for 48 h, treated with IGF-1 (50 ng/ml) for 4 h prior to UV irradiation at 40 J/m 2 . Cells were harvested 24 h after UV treatment and equal amount of total proteins was subjected for Western blot analysis for p21, HA (Y-l1, Santa Cruz), and actin IGF-1 activates p21 to inhibit UV-induced cell death S.A. Murray et al independent cell viability detection assay (Figure 5b ). The UV-induced cell death was primarily because of apoptosis since the majority (85%) of the cells treated with 40 J/m 2 exhibited positive TUNEL staining, whereas the percentage of TUNEL positive cells was reduced to 21% in the presence of IGF-1 (Figure 5c ).
Thus, these data indicate that IGF-1 protects MCF-7 cells from UV-mediated apoptosis.
p21 is important for IGF-1 survival function
Given that UV irradiation represses p21 expression and that IGF-1 can sustain p21 expression, we investigated ) and incubated for an indicated time in the absence or presence of IGF-1 (50 ng/ml). Cell lysates were subjected to Western bot analyses for p53, p21, pAKT, AKT, and actin, respectively Figure 6a , UV irradiation led to a reduced cell viability (30%) in wild-type MEF cells, whereas cell viability was significantly increased (60%) in the presence of IGF-1. In contrast, p21 À/À MEF cells were markedly sensitive to UV irradiation with less than 20% cell survival (Figure 6b ). Moreover, p21
À/À cells completely lost responsiveness to IGF-1 (Figure 6b ). Collectively, these data suggest that p21 is important for IGF-1 function in protecting cells from UV-induced apoptosis.
We further investigated the effect of ectopic expression of p21 in cell survival upon UV irradiation. MCF-7 and p21
À/À MEF cells were infected by a recombinant adenovirus encoding p21 (Ad-p21) at increasing MOIs. Increasing levels of Ad-p21 infection resulted in a marked increase in cell survival in the absence of IGF-1. As shown in Figure 6c , UV irradiation of MCF-7 cells resulted in a much reduced cell viability (26%) in the absence of IGF-1, but a significant higher cell survival (60%) in the presence of IGF-1. Ectopic expression of p21 in MCF-7 cells led to as high as 48% of cell viability upon UV irradiation in the absence of IGF-1. Furthermore, UV irradiation on p21 À/À MEF cells resulted in low cell viability (17%), whereas IGF-1 treatment exhibited a little effect. Similarly, ectopic expression of p21 in p21 À/À MEF cells led to significant increase in cell viability up to 40% (Figure 6d) . Thus, ectopic expression of p21 can protect cells from apoptosis in the absence of IGF-1, suggesting that p21 can function as a downstream survival factor in the IGF-1 signaling pathway.
Discussion
It is well established that IGF-1/Akt pathway plays a central role in survival signaling. Notably, IGF-1 activation of PI-3 kinase/Akt has been shown to protect cells from apoptosis induced by chemotherapy (Geier et al., 1995; Gooch et al., 1999) . Akt has been shown to directly phosphorylate and regulate several components in the p53 pathway, such as p21 (Rossig et al., 2001; Zhou et al., 2001a) and MDM2 (Mayo and Donner, 2001; Zhou et al., 2001b) . In this study, we presented evidence that IGF-1/Akt can elevate p21 protein expression through the p53-dependent transcriptional activation. First, IGF-1 can increase p21 mRNA levels. Second, the activity of a p53-responsive p21-luciferase reporter is increased upon IGF-1 treatment. Third, cells lacking p53 are unresponsive to IGF-1 with regard to p21 protein expression, although these cells are capable of activation of Akt in response to IGF-1.
The effect of IGF-1 on the activation of p21 requires PI-3 kinase and the Akt activity. Ectopic expression of Akt alone can stimulate p21 expression in the absence of IGF-1. On the other hand, inhibition of endogenous Akt activity by a dominant-negative Akt mutant effectively blocks the IGF-1-mediated upregulation of p21. These data indicate that IGF-1-mediated upregulation of p21 is primarily through Akt function, in agreement with the previous observations that PI3-kinase/Akt is required for induction of p21 by cisplatin and paclitaxel (Mitsuuchi et al., 2000) .
Consistent with the observation that UV irradiation inhibits the expression of p21 and MDM2 (Lu et al., 1996; McKay et al., 1998; Wang et al., 1999) , we found that the high dose of UV irradiation significantly suppresses p21 and MDM2 protein expression. Interestingly, this suppression is prevented in the presence of IGF-1. Notably, IGF-1/Akt has been shown to inhibit JNK activity and the expression of c-Jun (Okubo et al., 1998; Shimoke et al., 1999) , which inhibits p53 binding to p21 promoter upon UV irradiation (Shaulian et al., 2000) . Therefore, it is possible that IGF-1 may target À/À MEF cells (d) were infected with a recombinant adenovirus encoding p21 with an increased MOI. At 16 h postinfection, cells were serum starved for 48 h in serum-free (for MCF-7) or 0.5% FBS (for MEFs) prior to UV irradiation at a dose of 40 J/m 2 (MCF-7) or 60 J/m 2 (MEF). Where indicated, serum-starved cells were pretreated by IGF-1 (50 ng/ml) prior to UV treatment. At 20 h after UV irradiation, floating and adherent cells were collected and cell viability was determined by trypan blue exclusion assay. Cell viability is presented as the percentage of living cells to the total number of cells and is the mean of three independent experiments performed in triplicate with standard deviation IGF-1 activates p21 to inhibit UV-induced cell death S.A. Murray et al c-Jun to release the c-Jun-mediated inhibition of p53 upon UV damage and allow p21 expression. The effect of IGF-1 on p21 expression appears to be complex. Several recent reports have shown that Akt can directly bind to and phosphorylate p21 on Thr-145 (Rossig et al., 2001; Zhou et al., 2001a) . Phosphorylation of p21 by Akt leads to an enhanced cell proliferative capacity because of its relocalization to the cytoplasm, restricting access to cyclin/cdk complexes and thereby promoting growth (Zhou et al., 2001a) . Phosphorylated p21 may display reduced PCNA interaction capacity, resulting in enhanced proliferation (Rossig et al., 2001 ). Interestingly, Akt-mediated p21 phosphorylation may promote p21 cytoplasmic localization and protein stability, which in turn appears to promote survival in response to chemotherapy treatment (Li et al., 2001) . It is also suggested that Akt-mediated inhibition of GSK-3 activity may contribute to p21 protein stabilization (Rossig et al., 2002) . Our findings, however, demonstrate a direct transcriptional upregulation of p21, adding another level of regulation. It is plausible that a direct modification of p21 or alteration of p21 expression level or the combination of both may all contribute to the biological function of IGF-1 under certain circumstances. In fact, our data indicate that p21 protein is elevated prior to p53 protein accumulation, suggesting that IGF-1/Akt may also directly modulate p21 protein.
The IGF-1-mediated upregulation of p21 has an important biological significance. Increasing evidence indicate that p21 is an important survival factor. Cells lacking p21 alleles fail to arrest upon DNA damage (Brugarolas et al., 1995) and become hypersensitive to induction of apoptosis . Similarly, homozygous deletion of p53 and p21 sensitizes colon cancer cells to apoptosis induced by DNA damage (Bunz et al., 1999) . The survival role of p21 in IGF-1 signaling has been implicated in muscle cell differentiation (Lawlor and Rotwein, 2000a,b) . Here, we demonstrate that IGF-1 survival function upon UV irradiation requires the induction of p21.
Our data indicate that IGF-1 can lead to p53 protein accumulation and activation through Akt function. IGF-1 does not appear to alter p53 mRNA levels, but does lead to substantial increase in p53 protein stability. Since that tumor suppressor protein p14ARF can be activated by abnormal oncogenic signals (Sherr and Weber, 2000) , and p14ARF can bind to and inhibit MDM2 thereby activating p53 (Kamijo et al., 1998; Pomerantz et al., 1998; Stott et al., 1998; Zhang et al., 1998) , it is possible that IGF-1 may activate p14ARF which in turn activates p53. However, the effect of IGF-1 on p21 protein levels is observed in MEF cells lacking the ARF alleles (data not shown), suggesting that IGF-1/Akt is signaling at least partially through a mechanism(s) independent of p14ARF. Since p53 functions as a gatekeeper against abnormal cell growth and genomic instability, it is conceivable that abnormal proliferation signals such as high levels of IGF-1 may trigger the cellular tumor surveillance machinery involved in the p53 pathway, which restrains the abnormal cell proliferation.
Materials and methods
Cells, cell culture, and treatments MCF-7 human breast carcinoma cells and the wild-type, p53 null, and p21 null mouse embryo fibroblasts (MEFs, from Drs Tyler Jacks and Chuxia Deng) were maintained in DMEM plus 10% (v/v) heat-inactivated fetal bovine serum (Gibco), penicillin and streptomycin (100 U/ml) and l-glutamine (2 mm) at 371C and 5% CO 2 . Prior to IGF-1 or UVC treatment, MCF-7 cells at a density of 60-70% confluence were serum starved for 48 h in serum-free DMEM. MEF cells were serum starved in DMEM containing 0.5% FBS.
IGF-1 (human recombinant; Sigma) was prepared as a 100 mg/ml stock solution in 0.1% bovine serum albumin (BSA) in PBS according to the manufacturer's instructions. Inhibitors LY294002, PD98059, and SB202190 (Calbiochem) were prepared as 1000 Â stock solutions. At 45 min prior to IGF-1 treatment, LY294002, PD98059, or SB202190 was added to serum-deprived cells at final concentrations of 10, 50 and 10 mm, respectively.
For determining p53 protein half-life, MCF-7 cells were serum starved for 48 h and treated with IGF-1 (50 ng/ml) for 24 h. Cells were washed twice and incubated with DMEM containing IGF-1 (50 ng/ml) in the presence of 50 mg/ml cycloheximide for an indicated time. A total of 25 mg of total cellular protein was separated by 10% SDS-polyacrylamide gel electrophoresis (PAGE) and subjected to Western blot analysis for p53 or actin. The p53 protein levels were quantitated by densitometry scanning, normalized to actin. The percentage of remaining p53 protein was plotted versus time.
For UV treatment, media were removed and irradiated with lids removed in a Spectrolinker XL-1000 UV Crosslinker (Spectronics Corporation) at energies ranging from 20 to 60 J/m 2 . Media were returned to the dishes and the cells were grown for an indicated time before both floating and adherent cells collected and analysed.
Western blot analysis
Cells were collected, washed in PBS, and resuspended in the lysis buffer (125 mm NaCl, 25 mm Tris pH 7.4, 0.5% NP-40, 50 mm NaF, 0.5 mm NaVO 4 , 0.2 mm phenylmethylsulfonyl fluoride, 20 mg/ml aprotinin, and 10 mg/ml leupeptin). Protein concentration was determined using the Bio-Rad Protein Assay Reagent (Bio-Rad). An equal amount of protein (20-60 mg) was loaded, separated on a 10% SDS-PAGE, and then transferred to Immobilon-p membrane (Millipore). Monoclonal antibody DO-1 specific for p53 (Santa Cruz) was used at a dilution of 1 : 250. Monoclonal antibody SXM30 specific for p21 (PharMingen) was used at 1 : 200 and goat polyclonal C-11 for actin (Santa Cruz) was used at 1 : 1000. Akt-specific and phospho-serine 473-specific polyclonal antibodies (Cell Signaling Technology) were used at 1 : 1000 dilution. MDM2-specific monoclonal antibodies 2A10, 3F3, 4B2, and 4B11 (from Dr Jiandong Chen) were mixed and used as a cocktail.
Northern blot analysis
Cells were collected and lysed in Trizol reagent (Gibco). Total RNA was isolated according to the manufacture's instruction. A measure of 10 mg of total RNA was resolved on a formaldehyde/agarose gel, and transferred to a Hybond-XL nylon membrane (Amersham). A PCR-fragment (222-538 bp) probe for human p21 was labeled with the Redi-Prime II random prime labeling kit (Amersham) and hybridized using Quick-Hyb (Stratagene). Films were scanned and densities determined using Lab Works Analysis Software v. 3.0.02 (Ultra-Violet Products).
Transfection and recombinant viral infections
Cells were grown in six-well tissue culture dishes to approximately 70% confluency and transfected with 0.2 mg of pCMVb-gal, 0.5 mg of MDM2-luc or p21-luc reporter plasmids using FuGENE-6 (Roche Molecular Biochemicals). At 24 h after transfection, cells were washed and serum starved for 48 h prior to the addition of IGF-1 (50 ng/ml). Cell lysates were collected in 1 Â Reporter Lysis Buffer (Promega) after 24 h treatment. b-gal and luciferase assays were performed. After normalized to b-gal activity, the luciferase activity was presented as the mean of two independent experiments performed in triplicate.
The recombinant adenovirus encoding wild-type Akt, catalytically inactive, dominant-negative Akt (from Drs Wataru Ogawa and Takashi Matsu) (Kitamura et al., 1998) , or p21 (from Dr Cyrus Vazari) (Nghiem et al., 2001) were used to infect cells. Cells were grown to a density of 40-50% and infected with the virus, grown in regular media containing 10% FBS for 16 h prior to serum starvation and UV treatment.
Cell viability assays
Cells were collected and resuspended in PBS. Equal volume of trypan blue stain solution (0.4%) and cell suspension were mixed and stained for 10 min at room temperature. The numbers of stained and unstained cells were counted with a hemacytometer. At least 500 cells were counted per experiment time point. The percentage of viability represents the ratio of unstained cells to total cells. The ProCheck Cell Viability Assay (Intergen) was used to monitor viability as determined by the amount of actively metabolizing cells. Briefly, cells were collected, resuspended in media and counted. Equal numbers of cells (2000) were seeded into 96-well microtitre plates. After addition of reagent, cells were incubated at 371C for 1-2 h and OD at 475 nm was read on a ThermoMax microplate reader (Molecular Devices). TUNEL assays were performed on cells using the In Situ Cell Death Detection Kit (Roche) and mounted in Vectashield Mounting Media with Propidium Iodide (Vector).
